NFASC and neuropathy: Thus, the full expression of the disease in GAN mice, required to perform preclinical therapeutic studies, might be achieved by exacerbation of NF collapse, by genetically modulating NF stochiometry or by using chemical neurotoxins [7,34] such as acrylamide, that produces a neuropathy resembling human GAN with accumulation of NFs [35].